Synchrony Medical Receives 510(k) FDA Clearance for LibAirty™ Airway Clearance System for At-Home Respiratory Relief

JERSEY CITY, N.J. and OR YEHUDA, Israel, July 10, 2025 /PRNewswire/ -- Synchrony Medical, a medical technology company dedicated to advancing respiratory care, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its LibAirty™ Airway Clearance System in the United States.

The LibAirty System addresses a critical need for patients living with chronic lung diseases such as chronic obstructive pulmonary disease (COPD), bronchiectasis, and cystic fibrosis. “For millions of people, effective airway clearance is vital for reducing symptoms, improving quality of life, slowing disease progression, and preventing infections that often lead to costly hospitalizations. Unfortunately, many patients still lack access to effective airway clearance solutions they can use routinely at home,” explains Dr. Moshe Ashkenazi, co-founder of Synchrony Medical and Senior Pediatric Pulmonologist at Sheba Medical Center.

LibAirty is the first airway clearance system that synchronizes controlled breathing with targeted chest compressions – offering clinically-proven superior airway clearance. Clinical studies conducted at the Medical University of South Carolina (MUSC) and Sheba Medical Center demonstrated that LibAirty was twice as effective compared to traditional vest-based therapy, alongside higher user satisfaction scores.[1]

Sign up for Blog Updates